Summary:
Evanston Premier Healthcare Research is conducting a study involving an investigational medication for Type 2 diabetes. The study is 8 weeks long with 10 site visits.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Be diagnosed with Type 2 Diabetes for 6 months
•
Be on a stable dose of insulin greater than or equal to 30 units per day and up to 2 oral meds
OR
Be on a stable dose of metformin greater than or equal to 1500 mg per day
Qualified Participants May Receive:
$600 compensation for completion of the study.